
Intratumoral injection drives local and systemic anti-cancer activity
eBioMedicine, a Lancet Discovery Science journal, has published Intensity Therapeutics’ Phase I/II IT-01 clinical study manuscript for the treatment of metastatic or refractory cancers. According to the data, in heavily pretreated patients with advanced disease having over 20 different types of cancer who had progressed following… Read More












